APA (7th ed.) Citation

Elborn, J. S., Geller, D. E., Conrad, D., Aaron, S. D., Smyth, A. R., Fischer, R., . . . Flume, P. (2015). A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients. Elsevier.

Chicago Style (17th ed.) Citation

Elborn, J. Stuart, et al. A Phase 3, Open-label, Randomized Trial to Evaluate the Safety and Efficacy of Levofloxacin Inhalation Solution (APT-1026) Versus Tobramycin Inhalation Solution in Stable Cystic Fibrosis Patients. Elsevier, 2015.

MLA (9th ed.) Citation

Elborn, J. Stuart, et al. A Phase 3, Open-label, Randomized Trial to Evaluate the Safety and Efficacy of Levofloxacin Inhalation Solution (APT-1026) Versus Tobramycin Inhalation Solution in Stable Cystic Fibrosis Patients. Elsevier, 2015.